As innovation accelerates, life sciences companies must align patent strategy with long-term growth. This update explores how portfolio design, operational structure, and early IP decisions shape flexibility, commercialization, and long-term value.

Early-stage IP decisions in life sciences often occur under pressure but carry long-term implications for licensing, valuation, and portfolio flexibility. This article explores how early patent strategy shapes commercialization outcomes.

Understanding intellectual property is essential for innovators and early-stage businesses. At Hylton-Rodic Law, we’re often asked these key questions, here are our quick answers to help you get started.